Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives

We focused on a paper titled “Radiation with immunotherapy may be a double-edged sword—how can we learn from recent negative clinical trials?”, which was published in JAMA Oncology recently. Herein, we initially provided three complementary viewpoints from biological perspectives involved in the dyn...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanmei Liu, Ganghui Ye, Weijun Chen, Yan Ding, Shenpeng Ying, Shixiu Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1578486/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225292031197184
author Yanmei Liu
Ganghui Ye
Weijun Chen
Yan Ding
Shenpeng Ying
Shixiu Wu
author_facet Yanmei Liu
Ganghui Ye
Weijun Chen
Yan Ding
Shenpeng Ying
Shixiu Wu
author_sort Yanmei Liu
collection DOAJ
description We focused on a paper titled “Radiation with immunotherapy may be a double-edged sword—how can we learn from recent negative clinical trials?”, which was published in JAMA Oncology recently. Herein, we initially provided three complementary viewpoints from biological perspectives involved in the dynamic alterations of the tumor microenvironment, which may contribute to a more comprehensive understanding of the superiority of stereotactic body radiation therapy (SBRT).
format Article
id doaj-art-ee782daad52143a2928960a45a6a50ba
institution Kabale University
issn 1664-3224
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-ee782daad52143a2928960a45a6a50ba2025-08-25T05:25:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-08-011610.3389/fimmu.2025.15784861578486Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectivesYanmei LiuGanghui YeWeijun ChenYan DingShenpeng YingShixiu WuWe focused on a paper titled “Radiation with immunotherapy may be a double-edged sword—how can we learn from recent negative clinical trials?”, which was published in JAMA Oncology recently. Herein, we initially provided three complementary viewpoints from biological perspectives involved in the dynamic alterations of the tumor microenvironment, which may contribute to a more comprehensive understanding of the superiority of stereotactic body radiation therapy (SBRT).https://www.frontiersin.org/articles/10.3389/fimmu.2025.1578486/fullSBRTtumor microenvironmentradiosensitivityimmunotherapyimmune checkpoint inhibitors
spellingShingle Yanmei Liu
Ganghui Ye
Weijun Chen
Yan Ding
Shenpeng Ying
Shixiu Wu
Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
Frontiers in Immunology
SBRT
tumor microenvironment
radiosensitivity
immunotherapy
immune checkpoint inhibitors
title Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
title_full Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
title_fullStr Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
title_full_unstemmed Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
title_short Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
title_sort stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors from biological perspectives
topic SBRT
tumor microenvironment
radiosensitivity
immunotherapy
immune checkpoint inhibitors
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1578486/full
work_keys_str_mv AT yanmeiliu stereotacticbodyradiationtherapyorconventionalfractionatedradiotherapycombinedwithimmunecheckpointinhibitorsfrombiologicalperspectives
AT ganghuiye stereotacticbodyradiationtherapyorconventionalfractionatedradiotherapycombinedwithimmunecheckpointinhibitorsfrombiologicalperspectives
AT weijunchen stereotacticbodyradiationtherapyorconventionalfractionatedradiotherapycombinedwithimmunecheckpointinhibitorsfrombiologicalperspectives
AT yanding stereotacticbodyradiationtherapyorconventionalfractionatedradiotherapycombinedwithimmunecheckpointinhibitorsfrombiologicalperspectives
AT shenpengying stereotacticbodyradiationtherapyorconventionalfractionatedradiotherapycombinedwithimmunecheckpointinhibitorsfrombiologicalperspectives
AT shixiuwu stereotacticbodyradiationtherapyorconventionalfractionatedradiotherapycombinedwithimmunecheckpointinhibitorsfrombiologicalperspectives